Cargando…
"Indeterminate lupus anticoagulant" as the third category
Autores principales: | Park, Sang Hyuk, Jang, Seongsoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317480/ https://www.ncbi.nlm.nih.gov/pubmed/22479284 http://dx.doi.org/10.5045/kjh.2012.47.1.83 |
Ejemplares similares
-
Indeterminate lupus anticoagulant results: Prevalence and clinical significance
por: Alkayed, Khaldoun, et al.
Publicado: (2011) -
Suitability of EDTA-anticoagulated Blood for Natural Killer Cell Activity Testing Using Flow Cytometry
por: Ryu, Jeayeon, et al.
Publicado: (2023) -
Leukemic manifestation of blastic plasmacytoid dendritic cell neoplasm: laboratory approaches in 2 cases
por: Park, Sang Hyuk, et al.
Publicado: (2014) -
Rapid Disappearance of Lupus Anticoagulant in Novel Coronavirus 2019 Patients; Is It the Key to Pandora's Box?
por: Kim, Hyunji, et al.
Publicado: (2021) -
Transient endothelial injury and release of lupus anticoagulant in COVID-19
por: Trimaille, Antonin, et al.
Publicado: (2021)